MMP3 and nasopharyngeal carcinoma: Our study also demonstrated that the MMP3-activated pro-drug or in vivo diagnostic probe, which could be degraded in peripheral blood, could be ineffective in the treatment and diagnosis for MMP3 over-expressed tumor types, such as NPC.